Belarus Pharmaceuticals and Healthcare Report Q4 2013

Date: October 16, 2013
Pages: 87
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B0BEE68FA17EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: We have decided not to alter our near-term outlook for the Belarusian pharmaceutical market this quarter. We continue to regard factors such as local currency devaluation, state dominance in pharmaceutical manufacturing and regulatory bias against foreign producers as being instrumental in shaping the development of the country's pharmaceutical market. While demographic and epidemiological factors are conducive to larger volume consumption of treatments targetting non-communicable diseases in particular, economic uncertainty and substantial out-of-pocket expenses will continue to hamper concerted gains in this direction.
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Belarus Pharmaceutical Sales, Historical Data and Forecasts, 2009-2017
Healthcare Market Forecast
  Table: Belarus Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
  Table: Belarus Government Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
  Table: Belarus Private Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
Prescription Drug Market Forecast
  Table: Belarus Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017
Patented Drug Market Forecast
  Table: Belarus Patented Drug Market Indicators, Historical Data and Forecasts. 2009-2017
Generic Drug Market Forecast
  Table: Belarus Generic Drug Market Indicators, Historical Data and Forecasts, 2009-2017
OTC Medicine Market Forecast
  Table: Belarus Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017
Pharmaceutical Trade Forecast
  Table: Belarus Pharmaceutical Trade Data And Forecasts (US$mn), 2009-2017
  Table: Belarus Pharmaceutical Trade Data And Forecasts (BYRmn), 2009-2017
Other Healthcare Data
Key Risks To BMI's Forecasts
Macroeconomic Forecasts
Economic Analysis
  Table: Belarus - Economic Activity
Industry Risk Reward Ratings
Central And Eastern Europe Risk/Reward Ratings
Belarus Risk/Reward Ratings
Belarus's Pharmaceutical RRRs
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Provision
Healthcare Sector Reforms
Healthcare Insurance
Medical Tourism
Research And Development
Biotechnology
Clinical Trials
Regulatory Development
Recent Regulatory Developments
Customs Union
Pharmaceutical Advertising
Intellectual Property Rights
Counterfeit Drugs
Pricing And Reimbursement
Tendering Procedures
Competitive Landscape
Pharmaceutical Sector
Domestic Drugmakers
Foreign Drugmakers
Recent Pharmaceutical Sector Developments
Pharmaceutical Wholesale And Retail
Company Profile
Belbiopharm
Lekpharm
Demographic Forecast
  Table: Belarus' Population By Age Group, 1990-2020 ('000)
  Table: Belarus' Population By Age Group, 1990-2020 (% of total)
  Table: Belarus' Key Population Ratios, 1990-2020
  Table: Belarus' Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings
Belarus Pharmaceuticals and Healthcare Report Q2 2014 US$ 1,295.00 Mar, 2014 · 84 pages
Belarus Pharmaceuticals and Helathcare Report Q3 2012 US$ 1,295.00 Aug, 2012 · 66 pages
Thailand Pharmaceuticals and Healthcare Report Q2 2014 US$ 1,295.00 Feb, 2014 · 115 pages
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014 US$ 1,295.00 Apr, 2014 · 78 pages

Ask Your Question

Belarus Pharmaceuticals and Healthcare Report Q4 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: